Jonathan Cotliar - 12 Aug 2023 Form 4 Insider Report for Science 37 Holdings, Inc.

Role: Chief Medical Officer
Signature: /s/ Christine Pellizzari, Attorney-in-fact for Jonathan Cotliar
Issuer symbol: N/A
Transactions as of: 12 Aug 2023
Net transactions value: -$35,129
Form type: 4
Filing time: 15 Aug 2023, 16:23:12 UTC
Previous filing: 02 May 2023
Next filing: 12 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SNCE	Common Stock	Options Exercise	$0	+230,882	+24%	$0.000000	1,174,970	12 Aug 2023	Direct	F1
transaction	SNCE	Common Stock	Tax liability	$35,129	-79,839	-6.8%	$0.4400	1,095,131	12 Aug 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SNCE	Restricted Stock Units	Options Exercise	$0	-230,882	-33%	$0.000000	461,764	12 Aug 2023	Common Stock	230,882		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquisition of common stock resulting from vesting of the restricted stock units granted to Mr. Cotliar on August 12, 2022.
F2	Disposition of common stock resulting from the withholding of securities for the payment of tax liability relating to the vesting of restricted stock units granted to Mr. Cotliar on August 12, 2022.
F3	Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock.
F4	On August 12, 2022, Mr. Cotliar received restricted stock units representing 692,646 shares subject to a three-year vesting schedule, vesting 33 1/3% on the first, second and third anniversaries of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.